Study S001280

A Multi-centre, Prospective, Single-arm, Non-interventional Study Describing the Use of the Dose Check App in People Living With Type 2 Diabetes Mellitus and Treated With IDegLira in a Real-world Setting in Italy

ClinicalTrials.gov record

Registration

Registration: NCT06113341
Study type: OBSERVATIONAL
Status: WITHDRAWN
Enrollment: 0
Start: 2024-11-07
Primary completion: 2025-02-23
Lead sponsor: Novo Nordisk A/S
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:IDegLira
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:U1111-1288-8131

Registered primary outcomes

Participant downloaded and actively used the app (Yes/No) [From baseline (week 0) to end of the study (EOS) visit (week 26)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.